Protein aggregation propensity is a crucial determinant of intracellular inclusion formation and quality control degradation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 2714-2724

  Villar Piqué, Anna ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Amyloid peptide; Fluorescent reporter; Protein aggregation; Protein degradation; Protein folding; Yeast

Indexed keywords

ARTICLE; CELL INCLUSION; CELL VIABILITY; CYTOPLASM; DEGENERATIVE DISEASE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; IMMUNOBLOTTING; IN VIVO STUDY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; QUALITY CONTROL; SOLUBILITY;

EID: 84882799783     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.06.023     Document Type: Article

References (68)

1. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
2. Invernizzi G., Papaleo E., Sabate R., Ventura S. Protein aggregation: mechanisms and functional consequences. Int. J. Biochem. Cell Biol. 2012, 44:1541-1554.
3. Morell M., de Groot N.S., Vendrell J., Aviles F.X., Ventura S. Linking amyloid protein aggregation and yeast survival. Mol. Biosyst. 2011, 7:1121-1128.
4. Ventura S., Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 2006, 24:179-185.
5. Carrio M., Gonzalez-Montalban N., Vera A., Villaverde A., Ventura S. Amyloid-like properties of bacterial inclusion bodies. J. Mol. Biol. 2005, 347:1025-1037.
6. Wang L., Maji S.K., Sawaya M.R., Eisenberg D., Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 2008, 6:e195.
7. Morell M., Bravo R., Espargaro A., Sisquella X., Aviles F.X., Fernandez-Busquets X., Ventura S. Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim. Biophys. Acta 2008, 1783:1815-1825.
8. Dobson C.M. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356:133-145.
9. Rousseau F., Schymkowitz J., Serrano L. Protein aggregation and amyloidosis: confusion of the kinds?. Curr. Opin. Struct. Biol. 2006, 16:118-126.
10. Fitzpatrick A.W., Knowles T.P., Waudby C.A., Vendruscolo M., Dobson C.M. Inversion of the balance between hydrophobic and hydrogen bonding interactions in protein folding and aggregation. PLoS Comput. Biol. 2011, 7:e1002169.
11. Linding R., Schymkowitz J., Rousseau F., Diella F., Serrano L. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J. Mol. Biol. 2004, 342:345-353.
12. Espargaro A., Castillo V., de Groot N.S., Ventura S. The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case. J. Mol. Biol. 2008, 378:1116-1131.
13. Ventura S. Sequence determinants of protein aggregation: tools to increase protein solubility. Microb. Cell Factories 2005, 4:11.
14. Ventura S., Zurdo J., Narayanan S., Parreno M., Mangues R., Reif B., Chiti F., Giannoni E., Dobson C.M., Aviles F.X., Serrano L. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7258-7263.
15. Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003, 424:805-808.
16. Belli M., Ramazzotti M., Chiti F. Prediction of amyloid aggregation in vivo. EMBO Rep. 2011, 12:657-663.
17. Castillo V., Grana-Montes R., Sabate R., Ventura S. Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes. Biotechnol. J. 2011, 6:674-685.
18. Ahmed A.B., Kajava A.V. Breaking the amyloidogenicity code: methods to predict amyloids from amino acid sequence. FEBS Lett. 2013, 587:1089-1095.
19. Guidolin D., Agnati L.F., Albertin G., Tortorella C., Fuxe K. Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system. Electrophoresis 2012, 33:3669-3679.
20. de Groot N.S., Aviles F.X., Vendrell J., Ventura S. Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. FEBS J. 2006, 273:658-668.
21. de Groot N.S., Ventura S. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J. Biotechnol. 2006, 125:110-113.
22. Conchillo-Sole O., de Groot N.S., Aviles F.X., Vendrell J., Daura X., Ventura S. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinforma. 2007, 8:65.
23. de Groot N.S., Castillo V., Grana-Montes R., Ventura S. AGGRESCAN: method, application, and perspectives for drug design. Methods Mol. Biol. 2012, 819:199-220.
24. Espargaro A., Sabate R., Ventura S. Kinetic and thermodynamic stability of bacterial intracellular aggregates. FEBS Lett. 2008, 582:3669-3673.
25. Villar-Pique A., de Groot N.S., Sabate R., Acebron S.P., Celaya G., Fernandez-Busquets X., Muga A., Ventura S. The effect of amyloidogenic peptides on bacterial aging correlates with their intrinsic aggregation propensity. J. Mol. Biol. 2012, 421:270-281.
26. Khurana V., Lindquist S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast?. Nat. Rev. Neurosci. 2010, 11:436-449.
27. Tenreiro S., Outeiro T.F. Simple is good: yeast models of neurodegeneration. FEMS Yeast Res. 2010, 10:970-979.
28. Treusch S., Hamamichi S., Goodman J.L., Matlack K.E., Chung C.Y., Baru V., Shulman J.M., Parrado A., Bevis B.J., Valastyan J.S., Han H., Lindhagen-Persson M., Reiman E.M., Evans D.A., Bennett D.A., Olofsson A., DeJager P.L., Tanzi R.E., Caldwell K.A., Caldwell G.A., Lindquist S. Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 2011, 334:1241-1245.
29. D'Angelo F., Vignaud H., Di Martino J., Salin B., Devin A., Cullin C., Marchal C. A yeast model for amyloid-beta aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity. Dis. Model. Mech. 2013, 6:206-216.
30. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., Cao S., Caldwell K.A., Caldwell G.A., Marsischky G., Kolodner R.D., Labaer J., Rochet J.C., Bonini N.M., Lindquist S. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006, 313:324-328.
31. Outeiro T.F., Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 2003, 302:1772-1775.
32. Krobitsch S., Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1589-1594.
33. Willingham S., Outeiro T.F., DeVit M.J., Lindquist S.L., Muchowski P.J. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 2003, 302:1769-1772.
34. Tenreiro S., Munder M.C., Alberti S., Outeiro T.F. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration. J. Neurochem. 2013, 10.1111/jnc.1227.
35. Jones E.W. Tackling the protease problem in Saccharomyces cerevisiae. Methods Enzymol. 1991, 194:428-453.
36. Morimoto A., Irie K., Murakami K., Masuda Y., Ohigashi H., Nagao M., Fukuda H., Shimizu T., Shirasawa T. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement. J. Biol. Chem. 2004, 279:52781-52788.
37. Bitan G., Vollers S.S., Teplow D.B. Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J. Biol. Chem. 2003, 278:34882-34889.
38. Tartaglia G.G., Vendruscolo M. The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 2008, 37:1395-1401.
39. Garbuzynskiy S.O., Lobanov M.Y., Galzitskaya O.V. FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics 2010, 26:326-332.
40. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004, 22:1302-1306.
41. Bagriantsev S., Liebman S. Modulation of Abeta42 low-n oligomerization using a novel yeast reporter system. BMC Biol. 2006, 4:32.
42. Bharadwaj P.R., Verdile G., Barr R.K., Gupta V., Steele J.W., Lachenmayer M.L., Yue Z., Ehrlich M.E., Petsko G., Ju S., Ringe D., Sankovich S.E., Caine J.M., Macreadie I.G., Gandy S., Martins R.N. Latrepirdine (Dimebon) enhances autophagy and reduces intracellular GFP-Abeta42 levels in yeast. J. Alzheimers Dis. 2012, 32:949-967.
43. Villar-Pique A., Espargaro A., Sabate R., de Groot N.S., Ventura S. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb. Cell Factories 2012, 11:55.
44. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443:780-786.
45. Tanaka K., Mizushima T., Saeki Y. The proteasome: molecular machinery and pathophysiological roles. Biol. Chem. 2012, 393:217-234.
46. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., Rubinsztein D.C. Alpha-synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 2003, 278:25009-25013.
47. Rubinsztein D.C., Codogno P., Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 2012, 11:709-730.
48. Kaganovich D., Kopito R., Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature 2008, 454:1088-1095.
49. Petroi D., Popova B., Taheri-Talesh N., Irniger S., Shahpasandzadeh H., Zweckstetter M., Outeiro T.F., Braus G.H. Aggregate clearance of alpha-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome. J. Biol. Chem. 2012, 287:27567-27579.
50. Matsuura A., Tsukada M., Wada Y., Ohsumi Y. Apg1p, a novel protein kinase required for the autophagic process in Saccharomyces cerevisiae. Gene 1997, 192:245-250.
51. Woolford C.A., Daniels L.B., Park F.J., Jones E.W., Van Arsdell J.N., Innis M.A. The PEP4 gene encodes an aspartyl protease implicated in the posttranslational regulation of Saccharomyces cerevisiae vacuolar hydrolases. Mol. Cell. Biol. 1986, 6:2500-2510.
52. Emter R., Heese-Peck A., Kralli A. ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms. FEBS Lett. 2002, 521:57-61.
53. Jones E.W. Vacuolar proteases and proteolytic artifacts in Saccharomyces cerevisiae. Methods Enzymol. 2002, 351:127-150.
54. Kamada Y., Sekito T., Ohsumi Y. Autophagy in yeast: a TOR-mediated response to nutrient starvation. Curr. Top. Microbiol. Immunol. 2004, 279:73-84.
55. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998, 8:397-403.
56. Dobson C.M. Protein-misfolding diseases: getting out of shape. Nature 2002, 418:729-730.
57. Taylor J.P., Tanaka F., Robitschek J., Sandoval C.M., Taye A., Markovic-Plese S., Fischbeck K.H. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 2003, 12:749-757.
58. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 10:524-530.
59. Coquel A.S., Jacob J.P., Primet M., Demarez A., Dimiccoli M., Julou T., Moisan L., Lindner A.B., Berry H. Localization of protein aggregation in Escherichia coli is governed by diffusion and nucleoid macromolecular crowding effect. PLoS Comput. Biol. 2013, 9:e1003038.
60. Chen B., Retzlaff M., Roos T., Frydman J. Cellular strategies of protein quality control. Cold Spring Harb. Perspect. Biol. 2011, 3:a004374.
61. Chou P.Y., Fasman G.D. Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry 1974, 13:211-222.
62. Fredrickson E.K., Rosenbaum J.C., Locke M.N., Milac T.I., Gardner R.G. Exposed hydrophobicity is a key determinant of nuclear quality control degradation. Mol. Biol. Cell 2011, 22:2384-2395.
63. Wimley W.C., Creamer T.P., White S.H. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. Biochemistry 1996, 35:5109-5124.
64. Wimley W.C., White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 1996, 3:842-848.
65. Zhu X., Zhao X., Burkholder W.F., Gragerov A., Ogata C.M., Gottesman M.E., Hendrickson W.A. Structural analysis of substrate binding by the molecular chaperone DnaK. Science 1996, 272:1606-1614.
66. Fredrickson E.K., Gardner R.G. Selective destruction of abnormal proteins by ubiquitin-mediated protein quality control degradation. Semin. Cell Dev. Biol. 2012, 23:530-537.
67. Rideout H.J., Lang-Rollin I., Stefanis L. Involvement of macroautophagy in the dissolution of neuronal inclusions. Int. J. Biochem. Cell Biol. 2004, 36:2551-2562.
68. Neklesa T.K., Crews C.M. Chemical biology: greasy tags for protein removal. Nature 2012, 487:308-309.